4503
COM:ASTELLAS
Astellas Pharma Inc.
- Stock
market
STOCKSindustry
Pharmaceuticalswebsite
astellas.comcrunchbase
astellas-pharmaipo date
Jan 04, 2000
Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. It provides XTANDI, an androgen receptor signaling inhibitor for prostate cancer; XOSPATA, a FLT3 inhibitor for adult patients with relapsed or refractory acute myeloid leukemia with a FLT3 mutation-positive; PADCEV, a treatment solution for adult patients with locally a...Show More